Polydex Pharmaceuticals Ltd. (OTCMKTS:POLXF – Get Free Report) passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $1.99 and traded as low as $1.9860. Polydex Pharmaceuticals shares last traded at $1.9860, with a volume of 2,000 shares trading hands.
Polydex Pharmaceuticals Trading Up 0.3%
The business has a fifty day simple moving average of $1.99 and a 200 day simple moving average of $1.99.
About Polydex Pharmaceuticals
Polydex Pharmaceuticals Limited is a Canadian pharmaceutical company engaged in the development, manufacture and marketing of pharmaceutical products. The company’s operations have included products for both human and veterinary applications, with activities spanning pharmaceutical ingredients and finished dosage products.
Its product portfolio has included medicines and pharmaceutical chemicals used in areas such as anti-infective, antiseptic, analgesic, anesthetic and antihistamine treatments.
Featured Articles
- Five stocks we like better than Polydex Pharmaceuticals
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
- Conagra’s Turnaround Is Starting to Show Up in the Numbers
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
